Literature DB >> 1357288

Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery.

E Broussolle, M H Marion, P Pollak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1357288     DOI： 10.1016/0140-6736(92)92744-z

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

Authors:  C Trenkwalder; S Boesch; A Ceballos-Baumann; D Dressler; K Eggert; T Gasser; H Honig; T Müller; H Reichmann; J P Sieb; A Storch; P Odin; W Poewe
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

3.  Rotigotine transdermal system for perioperative administration.

Authors:  A D Korczyn; H Reichmann; B Boroojerdi; H-J Häck
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

4.  Evaluating Outcomes for Older Patients with Parkinson's Disease or Dementia with Lewy Bodies who have been Hospitalised for Hip Fracture Surgery: Potential Impact of Drug Administration.

Authors:  Marie Enemark; Mette Midttun; Kristian Winge
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

Review 5.  Current status of dopamine agonists in Parkinson's disease management.

Authors:  J L Montastruc; O Rascol; J M Senard
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

6.  Inpatient management of Parkinson disease: current challenges and future directions.

Authors:  Odinachi Oguh; Aleksandar Videnovic
Journal:  Neurohospitalist       Date:  2012-01

7.  Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-11

Review 8.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 9.  Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Authors:  Oliver H H Gerlach; Ania Winogrodzka; Wim E J Weber
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

Review 10.  The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Drugs R D       Date:  2018-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.